The global fertility tourism market was valued at USD 417.62 million in 2021 and it is predicted to surpass around USD 6.56 billion by 2030 with a CAGR of 35.8% from 2022 to 2030.

Lower cost of treatment in neighboring countries and a high success rate of IVF in countries such as Spain, U.S., and the U.K. are main factors due to which people are opting for reproductive tourism. Furthermore, the increasing rate of infertility due to factors such as high alcohol consumption, drug abuse, stress, and smoking is propelling the market.
Delayed pregnancy in women is favoring the market growth. Technological advancements and the introduction of IVF and various assisted reproductive technologies are likely to bode well with the market. Countries such as U.S., Spain, India, Czech Republic, are offering advanced treatments such as intracytoplasmic sperm injection, gamete intrafallopian transfer, Zygote intrafallopian transfer, and others. Many single women and gay or lesbian couples have to opt for reproductive tourism as the regulatory frameworks in their home counties do not allow them to avail treatments.
The COVID-19 pandemic adversely impacted the medical tourism industry. It shook the travel and tourism industry to its foundations. Prominent hospital service providers suffered heavy losses in 2020, as COVID-19 pandemic travel restrictions negatively affected medical services aimed at medical tourists. A sharp decline in the number of patient arrivals due to travel bans and strict regulations heavily impacted the fertility tourism industry.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 417.62 million |
| Revenue Forecast by 2030 | USD 6.56 billion |
| Growth rate from 2022 to 2030 | CAGR of 35.8% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Age Group, country |
| Companies Covered | San Diego Fertility Center; IVF-Life; Barcelona IVF; Eva Fertility Clinics; The Surrey Park Clinic; Bumrungrad International Hospital; Assisted Reproduction and Gynecology Centre; Sincere IVF Center; Alpha IVF & Women’s Specialists; Genesis IVF; Manchester Fertility Services Ltd; Apollo Fertility |
Age Group Insights
The 35-44 segment dominated the market with a share of 42.6% in 2021. The high incidence of infertility in this age group is a key factor in the growth of the segment. The cost and anonymity of ART-assisted treatments are the main reasons for travel. Additionally, the availability of more donors offered by international clinics, as well as the success rates advertised contribute to the segment growth.
The risk of pregnancy complications increases with age. Miscarriage and chromosomal abnormalities are more common in fetuses after the age of 35. In addition, the risk of pregnancy complications such as gestational diabetes, placenta previa (the placenta covering part of or all of the cervix), cesarean section, and stillbirth is also higher among older women. Thus, many women between the age group 35 to 44 seek treatment abroad.
The 45-54 segment is set to witness significant growth during the forecast period. High spending capacity and world-class treatment facilities in developed countries are primary factors for the growth of the segment. Furthermore, the efficient and reliable regulatory frameworks in international countries, such as U.S. and U.K. are increasing the influx of patients in the age group 45-54 to these countries.
Country Insights
Turkey dominated the market with a share of 42.19% in 2021. The availability of world-class IVF treatment services at a lower cost than in the U.S. and other European countries is responsible for the growth of the market in Turkey. Furthermore, the country witnessed a high influx of medical visitors in 2021, which rendered a dominating position to Turkey. According to the Turkish Statistical Institute, the country reported an increase of 61% in the arrival of international patients in 2021.
The market in Spain is likely to witness a notable growth rate due to the increasing number of patients from other European countries, rapid developments in fertility tourism, and the rising number of international fertility clinics. Thailand is one of the popular destinations for medical tourism. Its popularity as a tourist destination is augmenting its market growth. The growing number of private institutions, improvements in the overall healthcare infrastructure, and lower treatment prices all contribute to the country’s growth in reproductive tourism.
In recent years, the number of Chinese couples traveling overseas for IVF treatment has increased. The abolition of the one-child policy in China resulted in many older couples traveling to Thailand and Malaysia for IVF treatment. Both the countries are focussing on attracting Chinese patients. To compete with world-class medical centers and hospitals across Asia & other regions, Malaysia is forging a niche in fertility treatments. The country’s fertility centers also claim success rates that are well ahead of the global average.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1.Research Objective
1.2.Scope of the Study
1.3.Definition
Chapter 2. Research Methodology
2.1.Research Approach
2.2.Data Sources
2.3.Assumptions & Limitations
Chapter 3. Executive Summary
3.1.Market Snapshot
Chapter 4. Market Variables and Scope
4.1.Introduction
4.2.Market Classification and Scope
4.3.Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5.COVID 19 Impact on Fertility Tourism Market
5.1. COVID-19 Landscape: Fertility Tourism Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4.Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1.Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2.Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8. Global Fertility Tourism Market, By Age group
8.1.Fertility Tourism Market, by Age group Type, 2020-2027
8.1.1. 18 - 24
8.1.1.1.Market Revenue and Forecast (2016-2027)
8.1.2. 25 - 34
8.1.2.1.Market Revenue and Forecast (2016-2027)
8.1.3. 34 - 44
8.1.3.1.Market Revenue and Forecast (2016-2027)
8.1.4. 46 - 54
8.1.4.1.Market Revenue and Forecast (2016-2027)
Chapter 9. Global Fertility Tourism Market, Regional Estimates and Trend Forecast
9.1.North America
9.1.1. Market Revenue and Forecast, by Age group (2016-2027)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1.Market Revenue and Forecast, by Age group (2016-2027)
9.2.Europe
9.2.1. Market Revenue and Forecast, by Age group (2016-2027)
9.2.2. UK
9.2.2.1.Market Revenue and Forecast, by Age group (2016-2027)
9.2.3. France
9.2.3.1.Market Revenue and Forecast, by Age group (2016-2027)
9.2.4. Rest of Europe
9.2.4.1.Market Revenue and Forecast, by Age group (2016-2027)
Chapter 10.Company Profiles
10.1.San Diego Fertility Center
10.1.1.Company Overview
10.1.2.Product Offerings
10.1.3.Financial Performance
10.1.4.Recent Initiatives
10.2.IVF-Life
10.2.1.Company Overview
10.2.2.Product Offerings
10.2.3.Financial Performance
10.2.4.Recent Initiatives
10.3.Barcelona IVF
10.3.1.Company Overview
10.3.2.Product Offerings
10.3.3.Financial Performance
10.3.4.Recent Initiatives
10.4.Eva Fertility Clinics
10.4.1.Company Overview
10.4.2.Product Offerings
10.4.3.Financial Performance
10.4.4.Recent Initiatives
10.5.The Surrey Park Clinic
10.5.1.Company Overview
10.5.2.Product Offerings
10.5.3.Financial Performance
10.5.4.Recent Initiatives
10.6.Bumrungrad International Hospital
10.6.1.Company Overview
10.6.2.Product Offerings
10.6.3.Financial Performance
10.6.4.Recent Initiatives
10.7.Assisted Reproduction and Gynecology Centre
10.7.1.Company Overview
10.7.2.Product Offerings
10.7.3.Financial Performance
10.7.4.Recent Initiatives
10.8.Sincere IVF Center
10.8.1.Company Overview
10.8.2.Product Offerings
10.8.3.Financial Performance
10.8.4.Recent Initiatives
10.9.Alpha IVF & Women’s Specialists
10.9.1.Company Overview
10.9.2.Product Offerings
10.9.3.Financial Performance
10.9.4.Recent Initiatives
10.10.Genesis IVF
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11.Research Methodology
11.1.Primary Research
11.2.Secondary Research
11.3.Assumptions
Chapter 12.Appendix
12.1.About Us
12.2.Glossary of Terms